Activity of alpha- and theta-defensins against primary isolates of HIV-1
about
Reawakening retrocyclins: ancestral human defensins active against HIV-1Humanized theta-defensins (retrocyclins) enhance macrophage performance and protect mice from experimental anthrax infectionsSometimes it takes two to tango: contributions of dimerization to functions of human α-defensin HNP1 peptideThrough the looking glass, mechanistic insights from enantiomeric human defensinsInhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptidesHIV, sexual violence and special populations: adolescence and pregnancyAntiviral mechanisms of human defensinsOral antimicrobial peptides: Types and role in the oral cavityThe Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory TherapyMechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide developmentA novel small-molecule inhibitor of HIV-1 entryGrifonin-1: a small HIV-1 entry inhibitor derived from the algal lectin, GriffithsinThe structure of the major cell wall polysaccharide of Bacillus anthracis is species-specific.Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms.Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralizationDevelopment of topical microbicides to prevent the sexual transmission of HIVHuman antimicrobial peptides and proteinsSusceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safetyADP-ribosyltransferase-specific modification of human neutrophil peptide-1.Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection.Naturally occurring circular proteins: distribution, biosynthesis and evolution.HIV acquisition is associated with increased antimicrobial peptides and reduced HIV neutralizing IgA in the foreskin prepuce of uncircumcised men.Altered biomarkers of mucosal immunity and reduced vaginal Lactobacillus concentrations in sexually active female adolescents.Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes.Inhibition of HIV-1 infection by human α-defensin-5, a natural antimicrobial peptide expressed in the genital and intestinal mucosae.The chemistry and biology of theta defensins.Human beta-defensin 2 induces a vigorous cytokine response in peripheral blood mononuclear cells.HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells.Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity.A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs.The role of cell-associated virus in mother-to-child HIV transmission.HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor.Alpha-defensins in the prevention of HIV transmission among breastfed infants.Defensins and other antimicrobial peptides at the ocular surfaceRetrocyclins and their activity against HIV-1.Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II.Multifaceted mechanisms of HIV-1 entry inhibition by human α-defensinSurvey of the year 2004 commercial optical biosensor literature.Human Alpha-Defensin HNP1 Increases HIV Traversal of the Epithelial Barrier: A Potential Role in STI-Mediated Enhancement of HIV Transmission.
P2860
Q21145822-48813CC7-044A-4551-9A4E-695409B1D1F2Q24607197-849DA0AD-323A-4BDD-BE45-B16E3F274DAEQ24613395-FF36646F-9B48-4C03-9D5D-F428E934F703Q24652382-0AEF1AE5-55CE-4BD4-AABD-AFBA3C7E47BEQ24803217-88A95888-838F-45FA-8B29-88F3A8E8F84EQ26825943-E72AFCBB-5B17-4E26-82FB-97D090E9824FQ27023010-6A4EA947-BA9A-4F11-9BBC-6A44A7EB1D7AQ28077706-B9F53C1F-00BD-4DFF-8F8D-E3C53724BAF0Q28077916-B3597D71-64E3-46F9-876D-DA7353DA9A89Q28257799-DE4EF035-A26C-422E-89B3-D5A6D69143DCQ28606625-375523B9-9EAB-4363-9AC8-3E3F4B525A21Q28744163-04EA1891-6779-4495-B22F-60388B7EECE2Q33251880-54915346-6A63-40A3-AC60-5B827419603CQ33543787-6AE9D974-66C9-4038-B021-4415B69789D1Q33619244-17D6BD60-DAA5-4BC1-BC33-543E66267C0DQ33625073-324CB084-8801-4501-A94F-1E1FDE460BA6Q33673156-7F35779B-800F-42AD-A2D8-FD1963224B42Q33889911-473A9C27-9F8C-44B8-8EF0-1B89B5E6766CQ33995205-793C280E-6CC2-4663-AB28-665743C58042Q34124118-DC046447-D377-4A20-8718-8D228EE49838Q34137547-3A533D5F-FE38-4A07-98C3-844818790CC2Q34282935-64FC6419-F10F-48CA-81F7-E6612120EDBEQ34342009-25735EF1-2724-4A33-A958-309DA6003EE6Q34360372-77419E62-EEC8-4398-8247-83B5F981DFB8Q34428345-F40B97C9-3114-46DA-A0C9-98551E084A7CQ34431648-335289E0-C9D0-4210-B8EF-A0DB5B31B255Q34510378-62009546-A50A-4703-8B5E-2B6184D95822Q34554611-4A561B90-C37A-49A0-8BC2-B1F5047F6905Q34680240-1287A1CD-E621-4CAA-8DE4-C5C22994131CQ34758057-5C39A74C-79B8-4750-80E8-00E543472ACFQ34758093-6655EAF3-3FCA-4208-8394-855828BCBA02Q35000080-250F5427-CAE8-47B4-A9E0-4EB71025FA6BQ35542610-49BA980B-9EA7-473B-B6F1-448140BBDF13Q35577249-17F084E2-769A-4955-BC8F-3ADC307A9991Q35594084-C710A6C1-68B4-4F3D-854D-2CD5B83326DEQ35879590-47216033-E969-4C9A-BDC4-1461EFB73D83Q36158611-9A9DDDBE-09CD-42BA-BC79-93C87F9A61D4Q36217242-F40F8E1E-12DA-4C0A-A56F-6327935FD157Q36298435-B6B958C1-0EA9-4EFB-9A3D-CA79D8B23A43Q36367682-67FBDF39-D5A5-4996-B2CD-39CCDE683647
P2860
Activity of alpha- and theta-defensins against primary isolates of HIV-1
description
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im Juli 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/07/01)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/07/01)
@nl
наукова стаття, опублікована в липні 2004
@uk
مقالة علمية (نشرت في يوليو 2004)
@ar
name
Activity of alpha- and theta-defensins against primary isolates of HIV-1
@ast
Activity of alpha- and theta-defensins against primary isolates of HIV-1
@en
Activity of alpha- and theta-defensins against primary isolates of HIV-1
@nl
type
label
Activity of alpha- and theta-defensins against primary isolates of HIV-1
@ast
Activity of alpha- and theta-defensins against primary isolates of HIV-1
@en
Activity of alpha- and theta-defensins against primary isolates of HIV-1
@nl
prefLabel
Activity of alpha- and theta-defensins against primary isolates of HIV-1
@ast
Activity of alpha- and theta-defensins against primary isolates of HIV-1
@en
Activity of alpha- and theta-defensins against primary isolates of HIV-1
@nl
P2093
P3181
P1476
Activity of alpha- and theta-defensins against primary isolates of HIV-1
@en
P2093
Alan J. Waring
Alexander M. Cole
Donna L. Rudolph
Renu B. Lal
Robert I. Lehrer
Sherry M. Owen
Teresa Hong
P304
P3181
P356
10.4049/JIMMUNOL.173.1.515
P407
P577
2004-07-01T00:00:00Z